Table 4.
Reference | Modality | Sample Size | Mortality Ratea | Adjustment Technique | Relative Risk (95% CI) |
---|---|---|---|---|---|
Johansen et al.7 | NHD | 94 | 74 | Propensity score matchingb | 0.36 (0.22–0.61) |
SDHD | 43 | 91 | Propensity score matchingb | 0.64 (0.31–1.31) | |
Miller et al.8 | SDHD | 190 | 69 | Indirect standardizationc | 0.39 (0.22–0.64) |
Kjellstrand et al.9 | SDHD | 415 | 84 | Indirect standardizationd | 0.34 (0.20–0.54) |
Agar et al.10 | NHD | 72 | 65 | Indirect standardizatione | 0.42 (0.15–0.91) |
Blagg et al.11 | SDHD | 117 | 76 | Indirect standardizationf | 0.39 (0.19–0.51) |
NHD, nocturnal hemodialysis; SDHD, short daily hemodialysis.
Per 1000 patient-years.
Scored by age, race, sex, primary ESRD cause, ESRD duration, BMI, number of cardiovascular comorbid conditions, Medicaid status, and cumulative admissions and days for all-cause, cardiovascular-related, and vascular access-related hospitalizations during a maximum of 12 months preceding follow-up.
Standardized by age, race, and sex.
Standardized by age and primary ESRD cause.
Standardized by age, race, sex, primary ESRD cause, and ESRD duration.
Standardized by age, race, sex, and primary ESRD cause.